PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM CLEARED FOR PHASE 3 TRIAL BY US FDA, page-36

  1. 1,079 Posts.
    lightbulb Created with Sketch. 269
    Let the trials begin towards the final goal. And now we have a go for phase 3...Let the big pharma negotiations get serious

    I would like to see what the trial protocol changes are though. Hopefully we will get a detailed update at some point. Either way, we are so undervalued so we should now resume on the path of getting back to a realistic valuation (much higher!)
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.